Digital Content 
NEWS #PharmaBuzz
09 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/09/3184162/18362/en/New-REDUCE-IT-Aspirin-Analysis-Presented-at-AHA-Scientific-Sessions-2025-Reinforces-VASCEPA-VAZKEPA-Icosapent-Ethyl-Reduced-Cardiovascular-Events-in-High-Risk-Patients.html
03 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/03/3179271/18362/en/Amarin-To-Present-New-Analyses-Affirming-Robustness-of-Data-from-REDUCE-IT-and-Additional-Mechanisms-of-Action-of-Eicosapentaenoic-Acid-EPA-at-American-Heart-Association-AHA-Scient.html
14 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/14/3166085/18362/en/Amarin-and-HLS-Therapeutics-Collaborate-on-Presenting-REDUCE-IT-and-EPA-Mechanistic-Data-at-the-Canadian-Cardiovascular-Congress.html
25 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/25/3138380/18362/en/New-Analyses-from-REDUCE-IT-and-EPA-Mechanistic-Data-to-be-Presented-at-the-European-Society-of-Cardiology-ESC-Congress-2025.html
24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104106/18362/en/Amarin-Announces-Exclusive-License-and-Supply-Agreement-with-Recordati-to-Commercialize-VAZKEPA-Icosapent-Ethyl-in-Europe.html
18 Jun 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-18-2025-14246.pdf
Share 